Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Sutro Biopharma, Inc. (NASDAQ: STRO)
STRO Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-32.50%
Analyst Rating:
BUY
Analyst Forecast (1yr):
52.60%
STRO Stock Analysis
STRO
PE Ratio:
STRO
PEG Ratio:
Not Available
STRO
Forward EPS Growth (12 month):
0.00%
STRO
PS Ratio:
2.6
STRO
PSG Ratio:
-0.1
STRO
Forward Revenue Growth (12 month):
-29.50%
STRO Articles
No data was found